Skip to main content
. 2017 Oct 20;11:329. doi: 10.3389/fncel.2017.00329

Figure 3.

Figure 3

Effects of miR-148b on Wnt/β-catenin signaling activity. (A) miR-148b expression levels in ischemic NSCs transfected with miR-148b mimic or miR-148b-mimic-con; (B) miR-148b expression levels in ischemic NSCs transfected with miR-148b inhibitor or miR-148b inhibitor-con; (C–E). Western blot analysis of Wnt-1, β-catenin, Cyclin D1, NeuroD1, and Prox1 expression contents and their quantitative data in ischemic NSCs transfected with miR-148b mimic, miR-148b inhibitor and their negative controls. mean ± SE, *p < 0.05, **p < 0.01, n = 3/group.